I think there will be a fully concluded adult result being released before US Trial starts. Because the previous test was a preliminary test. In addition, I will not be surprised that the result of the Australia test is so far so good. RAP must be showing this result to US hospitals so that they are able to make the deal with the Top 10. Overall, it is a strong buy now if you don’t want to miss the boat. I feel so comfortable just to sit tight and receive 4 times return next year March.
Ann: Update on US Clinical Study-RAP.AX, page-37
Currently unlisted. Proposed listing date: 4 SEPTEMBER 2024 #